The 14th International Nanomedicine & Drug Delivery Symposium (nanoDDS’16) will be held at The Johns Hopkins University, Baltimore, Maryland, from September 16-18, 2016.
nanoDDS is the key annual event for researchers developing next-generation delivery vehicles — targeted, responsive, biodegradable nanomaterials to make diagnostics more sensitive and drugs more effective. In January 2003, Dr. Alexander Kabanov and Dr. Kazunori Kataoka have organized the first nanomedicine meeting in the United States – “The Nanomedicine and Drug Delivery Symposium (nanoDDS)”. Since then nanoDDS has been held annually in different locations across North America. Over years it has attracted more than 2,000 participants from 30 different countries and became one of the most authoritative forums in its field. Each year the meeting comes to a different University campus, thereby promoting knowledge and becoming a major world-class scientific event for its students and scholars. The objectives of nanoDDS are to 1) discuss groundbreaking discoveries and developments in nanomedicine and drug delivery; 2) highlight clinical developments and opportunities for advancing nanomedicine technology to the marketplace; and 3) engage and educate students, postdoctoral trainees and scientists from the local University and all over the world.
We are very excited to have the opportunity to bring this meeting to Baltimore, succeeding the past year’s event at the University of Washington, Seattle, which was co-organized by Patrick Stayton and Suzie Pun.
Co-Chair: Justin Hanes, Ph.D., Lewis J. Ort Professor
Ophthalmology, Biomedical Engineering, Chemical & Biomolecular Engineering, Environmental Health Sciences, Neurosurgery, and Oncology
Director, Center for Nanomedicine, Wilmer Eye Institute
The Johns Hopkins University